Compare Aurora Cannabis Inc (ACB) vs Zscaler Inc (ZS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aurora Cannabis Inc vs Zscaler Inc — how do they compare? Aurora Cannabis Inc trades at $3.8 (market cap $223.59M), while Zscaler Inc trades at $177.49 (market cap $28.87B). The key difference: Zscaler Inc is far larger — about 129.1× Aurora Cannabis Inc's market cap. Which is the better fit depends on your goals.
| ACB | ZS | |
|---|---|---|
Market Cap | $223.59M | $28.87B |
Sector | Health | Technology |
52-Week High | $6.23 | $336.27 |
52-Week Low | $2.58 | $118.05 |
Enterprise Value | $168.09M | $27.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aurora Cannabis (ACB) trades at $3.79, up 31.14% amid a hostile takeover bid from Curaleaf at $4 per share. The stock shows neutral technical signals with bearish moving averages. Fundamentally, 2025 revenue grew to $343.29M with a slim net profit of $1.59M, but 2026 projections indicate a net loss of $120M. Analyst consensus is mixed with 21.43% buy ratings, reflecting uncertainty over the acquisition offer and standalone prospects.
The outlook hinges on the takeover outcome; acceptance could provide immediate upside, while rejection may pressure shares given weak 2026 forecasts. Key risks include execution challenges, regulatory hurdles, and competitive pressures. Investors face a binary event driving near-term volatility.
Zscaler (ZS) trades at $176.11, showing modest daily movement. The stock exhibits a bullish technical trend with strong analyst support, evidenced by 42 buy ratings and a consensus price target of $191.81. Recent earnings consistently beat expectations, with Q1 2026 EPS of $1.08 surpassing the $1.01 forecast. Revenue growth is robust, increasing from $1.1B in 2022 to $2.67B in 2025, though the company remains unprofitable with a net income margin of -2.44%.
The outlook is positive due to strong revenue growth, leadership in cloud security, and bullish analyst sentiment. Key risks include persistent unprofitability, high valuation multiples like a P/S of 8.94, and competitive pressures in the cybersecurity sector. The upcoming Q2 2026 earnings report on September 3, 2026, will be critical for validating growth trajectory and investor confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aurora Cannabis Inc
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →About Zscaler Inc
Zscaler is a security-as-a-service firm that offers its customers cloud-delivered solutions for protecting user devices and data. The firm leverages its position in 150 colocation data centers to deliver traditionally appliance-based security functionality, such as firewalls and sandboxes, as a completely cloud-native platform. The firm focuses on large enterprise customers and offers two primary product suites: Zscaler Internet Access, which securely connects users to externally managed application and websites (such as Salesforce and Google), and Zscaler Private Access, which securely connects users to internally managed applications. Both product suites encompass a broad gamut of capabilities situated across the traditional security stack.
Read more on ZS →
